Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomas.

Autor: Reis H; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany., van der Vos KE; Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Niedworok C; Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany., Herold T; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany., Módos O; Department of Urology, Semmelweis University, Budapest, Hungary., Szendrői A; Department of Urology, Semmelweis University, Budapest, Hungary., Hager T; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany., Ingenwerth M; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany., Vis DJ; Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Behrendt MA; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Department of Surgery, Division of Urology, University Hospital of Basel, Basel, Switzerland., de Jong J; Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., van der Heijden MS; Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Peyronnet B; Department of Urology, University of Rennes, Rennes, France., Mathieu R; Department of Urology, University of Rennes, Rennes, France., Wiesweg M; Department of Medical Oncology, West German Cancer Center, University of Duisburg Essen, University Hospital Essen, Essen, Germany., Ablat J; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Okon K; Department of Pathomorphology, Jagiellonian University, Cracow, Poland., Tolkach Y; Institute of Pathology, University of Bonn, Bonn, Germany., Keresztes D; Department of Urology, Semmelweis University, Budapest, Hungary., Nagy N; Department of Urology, Semmelweis University, Budapest, Hungary., Bremmer F; Institute of Pathology, University of Göttingen, Göttingen, Germany., Gaisa NT; Institute of Pathology, RWTH Aachen University, Aachen, Germany., Chlosta P; Department of Pathomorphology, Jagiellonian University, Cracow, Poland., Kriegsmann J; Center for Histology, Cytology and Molecular Diagnostics Trier, Trier, Germany., Kovalszky I; First Institute of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary., Timar J; Second Department of Pathology, Semmelweis University, Budapest, Hungary., Kristiansen G; Institute of Pathology, University of Bonn, Bonn, Germany., Radzun HJ; Institute of Pathology, University of Göttingen, Göttingen, Germany., Knüchel R; Institute of Pathology, RWTH Aachen University, Aachen, Germany., Schuler M; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, West German Cancer Center, University of Duisburg Essen, University Hospital Essen, Essen, Germany., Black PC; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada., Rübben H; Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany., Hadaschik BA; Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany., Schmid KW; Institute of Pathology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany., van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., Nyirády P; Department of Urology, Semmelweis University, Budapest, Hungary., Szarvas T; Department of Urology, West German Cancer Center, University of Duisburg-Essen, University Hospital Essen, Essen, Germany.; Department of Urology, Semmelweis University, Budapest, Hungary.

Publikováno v: International journal of cancer [Int J Cancer] 2018 Oct 01; Vol. 143 (7), pp. 1764-1773. Date of Electronic Publication: 2018 May 10.

Long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with peritoneal metastases of urachal cancer.

Autor: Mertens LS; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Urology, VU University Medical Centre, Amsterdam, the Netherlands. Electronic address: l.mertens@nki.nl., Behrendt MA; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Urology, University Hospital of Basel, Basel, Switzerland., Mehta AM; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; Department of Surgery, Peritoneal Malignancy Institute, Basingstoke and North Hampshire Hospital, Hampshire Hospitals NHS Foundation Trust, Basingstoke, Hampshire, United Kingdom., Stokkel L; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., de Jong J; Department of Pathology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Boot H; Department of Gastroenterology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Horenblas S; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Moonen LM; Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Aalbers AGJ; Department of Surgery, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., Meinhardt W; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands., van Rhijn BWG; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. Electronic address: b.v.rhijn@nki.nl.

Publikováno v: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2019 Sep; Vol. 45 (9), pp. 1740-1744. Date of Electronic Publication: 2019 Apr 01.

Urachal cancer: contemporary review of the pathological, surgical, and prognostic aspects of this rare disease.

Autor: Behrendt MA; Department of Surgical Oncology, Division of Urology, The Netherlands Cancer Institute , Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands - b.v.rhijn@n., DE Jong J, VAN Rhijn BW

Publikováno v: Minerva urologica e nefrologica = The Italian journal of urology and nephrology [Minerva Urol Nefrol] 2016 Apr; Vol. 68 (2), pp. 172-84. Date of Electronic Publication: 2015 Nov 18.

Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.

Autor: Fransen van de Putte EE; aDepartment of Surgical Oncology, Division of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands bDivision of Urology, Department of Surgery, University Hospital of Basel, Basel, Switzerland cDepartment of Urology, VU University Medical Center, Amsterdam, The Netherlands dDepartment of Pathology, University Health Network, Toronto General Hospital, Toronto, Ontario, Canada., Behrendt MA, Pigot GL, van der Kwast TH, van Rhijn BW

Publikováno v: Current opinion in urology [Curr Opin Urol] 2015 Sep; Vol. 25 (5), pp. 427-35.

The impact of statins on FGF-2-stimulated human umbilical vein endothelial cells.

Autor: Burgazli KM; Department of Internal Medicine and Angiology, Wuppertal Research and Medical Center, Wuppertal, Germany. burgazlk@uni-koeln.de., Behrendt MA, Mericliler M, Chasan R, Parahuleva M, Erdogan A

Publikováno v: Postgraduate medicine [Postgrad Med] 2014 Jan; Vol. 126 (1), pp. 118-28.